Since SLC12A5 has been included in epilepsy genetic screening panels, the number of KCC2 mutant variants identified has exponentially grown in recent years (see ∼900 SLC12A5 variants identified to date on ClinVar). This evidence concerns the gene SLC12A5 and epilepsy.